Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
The Journal of Trauma
|
June 1, 1993
Is 24-hour operating room staff absolutely necessary for level II trauma center designation?
J E Barone, M C Ryan, C G Cayten, et al.
Journal of Neurochemistry
|
September 15, 2000
Role of the peripheral myelin protein 22 N-linked glycan in oligomer stability
M C Ryan, L Notterpek, A R Tobler, et al.
European Journal of Pharmacology
|
October 14, 1994
Heterocyclic amino alcohols related to ifenprodil as sigma receptor ligands: binding and conformational analyses
P M Beart, M C Ryan, L D Mercer, et al.
Kidney International
|
July 20, 2006
Abnormal development of glomerular endothelial and mesangial cells in mice with targeted disruption of the lama3 gene
C K Abrass, A K Berfield, M C Ryan, et al.
European Journal of Pharmacology
|
October 10, 1996
Structure-activity relationships of competitive NMDA receptor antagonists
N S Cheung, D O'Callaghan, M C Ryan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 6, 1998
Molecular analysis of the human laminin alpha3a chain gene (LAMA3a): a strategy for mutation identification and DNA-based prenatal diagnosis in Herlitz junctional epidermolysis bullosa
L Pulkkinen, P B Cserhalmi-Friedman, M Tang, et al.
Ground Water
|
June 11, 2013
Groundwater protection and unconventional gas extraction: the critical need for field-based hydrogeological research
R E Jackson, A W Gorody, B Mayer, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
December 1, 1996
The functions of laminins: lessons from in vivo studies
M C Ryan, A M Christiano, E Engvall, et al.
British Journal of Cancer
|
July 29, 2010
Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody-drug conjugate SGN-75
M C Ryan, H Kostner, K A Gordon, et al.
British Journal of Cancer
|
June 11, 2008
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
L M Smith, A Nesterova, M C Ryan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
The Journal of Trauma
|
June 1, 1993
Is 24-hour operating room staff absolutely necessary for level II trauma center designation?
J E Barone, M C Ryan, C G Cayten, et al.
Journal of Neurochemistry
|
September 15, 2000
Role of the peripheral myelin protein 22 N-linked glycan in oligomer stability
M C Ryan, L Notterpek, A R Tobler, et al.
European Journal of Pharmacology
|
October 14, 1994
Heterocyclic amino alcohols related to ifenprodil as sigma receptor ligands: binding and conformational analyses
P M Beart, M C Ryan, L D Mercer, et al.
Kidney International
|
July 20, 2006
Abnormal development of glomerular endothelial and mesangial cells in mice with targeted disruption of the lama3 gene
C K Abrass, A K Berfield, M C Ryan, et al.
European Journal of Pharmacology
|
October 10, 1996
Structure-activity relationships of competitive NMDA receptor antagonists
N S Cheung, D O'Callaghan, M C Ryan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 6, 1998
Molecular analysis of the human laminin alpha3a chain gene (LAMA3a): a strategy for mutation identification and DNA-based prenatal diagnosis in Herlitz junctional epidermolysis bullosa
L Pulkkinen, P B Cserhalmi-Friedman, M Tang, et al.
Ground Water
|
June 11, 2013
Groundwater protection and unconventional gas extraction: the critical need for field-based hydrogeological research
R E Jackson, A W Gorody, B Mayer, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
December 1, 1996
The functions of laminins: lessons from in vivo studies
M C Ryan, A M Christiano, E Engvall, et al.
British Journal of Cancer
|
July 29, 2010
Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody-drug conjugate SGN-75
M C Ryan, H Kostner, K A Gordon, et al.
British Journal of Cancer
|
June 11, 2008
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
L M Smith, A Nesterova, M C Ryan, et al.
Page
of 6